Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: a randomized multicentre study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: a randomized multicentre study
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 178, Issue 1, Pages 67-76
Publisher
Bioscientifica
Online
2017-10-10
DOI
10.1530/eje-17-0546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis
- (2016) G.A. Kanakis et al. CLINICAL ENDOCRINOLOGY
- HISTORICAL RESPONSE RATES OF SOMATOSTATIN ANALOGUES IN THE TREATMENT OF ACROMEGALY: A SYSTEMATIC REVIEW
- (2016) Michael H. Shanik et al. Endocrine Practice
- Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study
- (2016) Jakob Dal et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog Treatment
- (2016) Jakob Dal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL
- (2015) Kenichi Yoshida et al. Pituitary
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays
- (2011) D. R. Clemmons et al. CLINICAL CHEMISTRY
- Conventional and novel biomarkers of treatment outcome in patients with acromegaly: discordant results after somatostatin analog treatment compared with surgery
- (2010) Kristine Z Rubeck et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Hypothesis: Extra-hepatic acromegaly: a new paradigm?
- (2010) Sebastian J Neggers et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
- (2009) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
- (2008) I M Holdaway et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Divergence between Growth Hormone and Insulin-Like Growth Factor-I Concentrations in the Follow-Up of Acromegaly
- (2008) Orsalia Alexopoulou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Growth Hormone Response during Oral Glucose Tolerance Test: The Impact of Assay Method on the Estimation of Reference Values in Patients with Acromegaly and in Healthy Controls, and the Role of Gender, Age, and Body Mass Index
- (2008) Ayman M. Arafat et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Utility of Oral Glucose Tolerance Testing for Diagnosis and Assessment of Treatment Outcomes in 166 Patients with Acromegaly
- (2008) John D. Carmichael et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mortality in Acromegaly: A Metaanalysis
- (2007) O. M. Dekkers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now